Furthermore, for CYP2D6 and CYP2C9 related co-prescriptions, the kappa value of the OM-CM combination (fair agreement) was higher than OM-OM (poor agreement) except for CYP2C19. Here, CYP2D6 is linked to ocular melanoma.